|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
104,690,000 |
Market
Cap: |
108.27(B) |
Last
Volume: |
418,302 |
Avg
Vol: |
758,271 |
52
Week Range: |
$692.45 - $1071.19 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 150 |
Guru Rank Value : 6.9 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
192,995 |
237,237 |
312,646 |
469,880 |
Total Sell Value |
$189,656,342 |
$231,855,596 |
$295,997,978 |
$406,115,303 |
Total People Sold |
7 |
13 |
16 |
18 |
Total Sell Transactions |
18 |
40 |
67 |
129 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brown Michael S |
Director |
|
2011-03-30 |
4 |
D |
$44.35 |
$74,996 |
D/D |
(1,691) |
22,971 |
|
- |
|
Brown Michael S |
Director |
|
2011-03-30 |
4 |
OE |
$15.01 |
$75,050 |
D/D |
5,000 |
24,662 |
|
- |
|
Stahl Neil |
SVP Res and Dev Sciences |
|
2011-03-30 |
4 |
AS |
$45.00 |
$346,140 |
D/D |
(7,692) |
50,350 |
|
- |
|
Stahl Neil |
SVP Res and Dev Sciences |
|
2011-03-30 |
4 |
OE |
$13.00 |
$99,996 |
D/D |
7,692 |
58,042 |
|
- |
|
Mccorkle Douglas S |
VP Controller and Asst Treasur |
|
2011-03-21 |
4 |
AS |
$40.02 |
$424,212 |
D/D |
(10,600) |
0 |
|
- |
|
Mccorkle Douglas S |
VP Controller and Asst Treasur |
|
2011-03-21 |
4 |
OE |
$20.32 |
$215,392 |
D/D |
10,600 |
6,850 |
|
- |
|
Goldstein Joseph L |
Director |
|
2011-03-21 |
4 |
AS |
$40.00 |
$460,200 |
D/D |
(11,505) |
0 |
|
- |
|
Gilman Alfred G |
Director |
|
2011-03-17 |
4 |
AS |
$38.97 |
$66,249 |
D/D |
(1,700) |
11,875 |
|
- |
|
Gilman Alfred G |
Director |
|
2011-03-17 |
4 |
D |
$38.92 |
$714,065 |
D/D |
(18,347) |
13,575 |
|
- |
|
Gilman Alfred G |
Director |
|
2011-03-17 |
4 |
OE |
$18.80 |
$714,150 |
D/D |
30,000 |
20,820 |
|
- |
|
Brown Michael S |
Director |
|
2011-03-10 |
4 |
AS |
$39.09 |
$120,944 |
D/D |
(3,094) |
19,662 |
|
- |
|
Goldstein Joseph L |
Director |
|
2011-03-09 |
4 |
D |
$39.35 |
$137,528 |
D/D |
(3,495) |
11,505 |
|
- |
|
Goldstein Joseph L |
Director |
|
2011-03-09 |
4 |
OE |
$9.17 |
$137,550 |
D/D |
15,000 |
15,000 |
|
- |
|
Shooter Eric M |
Director |
|
2011-03-09 |
4 |
AS |
$40.00 |
$1,100,000 |
D/D |
(27,500) |
0 |
|
- |
|
Shooter Eric M |
Director |
|
2011-03-09 |
4 |
OE |
$18.61 |
$704,000 |
D/D |
27,500 |
15,000 |
|
- |
|
Brown Michael S |
Director |
|
2011-03-09 |
4 |
AS |
$40.00 |
$200,000 |
D/D |
(5,000) |
22,756 |
|
- |
|
Brown Michael S |
Director |
|
2011-03-09 |
4 |
D |
$39.35 |
$75,001 |
D/D |
(1,906) |
27,756 |
|
- |
|
Brown Michael S |
Director |
|
2011-03-09 |
4 |
OE |
$15.01 |
$75,050 |
D/D |
5,000 |
29,662 |
|
- |
|
Mccorkle Douglas S |
VP Controller and Asst Treasur |
|
2011-03-09 |
4 |
AS |
$40.00 |
$376,000 |
D/D |
(9,400) |
0 |
|
- |
|
Mccorkle Douglas S |
VP Controller and Asst Treasur |
|
2011-03-09 |
4 |
OE |
$20.32 |
$191,008 |
D/D |
9,400 |
1,988 |
|
- |
|
Terifay Robert J |
SVP Commercial |
|
2011-03-04 |
4 |
AS |
$38.00 |
$231,762 |
D/D |
(6,099) |
0 |
|
- |
|
Terifay Robert J |
SVP Commercial |
|
2011-03-04 |
4 |
OE |
$21.92 |
$133,690 |
D/D |
6,099 |
6,099 |
|
- |
|
Goldberg Murray A |
SVP F&A, CFO, Treas & Asst Sec |
|
2011-02-18 |
4 |
AS |
$36.87 |
$169,887 |
D/D |
(4,569) |
77,734 |
|
- |
|
Terifay Robert J |
SVP Commercial |
|
2011-02-17 |
4 |
AS |
$38.00 |
$1,858,238 |
D/D |
(48,901) |
0 |
|
- |
|
Terifay Robert J |
SVP Commercial |
|
2011-02-17 |
4 |
OE |
$21.34 |
$1,047,260 |
D/D |
48,901 |
6,401 |
|
- |
|
2433 Records found
|
|
Page 77 of 98 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|